Healthy Adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 18 years or older. Individuals classified as physical activity levels I or II.
Exclusion criteria
Exclusion criteria: Individuals with a history or current condition of mental illness, sleep disorders, hypertension, diabetes, dyslipidemia, or other serious diseases. Individuals who have habitually taken medication for the treatment of illness within the past month (excluding occasional use for headaches, menstrual pain, colds, etc.). Individuals with a history or current condition of severe impairment of the liver, kidneys, heart, lungs, blood, etc. Individuals with concomitant diseases or a history of severe conditions involving the digestive organs. Individuals currently suffering from a disease and receiving drug therapy. Individuals who have undergone surgery due to illness or injury (within 2 months prior to study start). Individuals whose weight fluctuated by more than 2 kg (within 3 months of the trial start date). Individuals who donated blood exceeding 200 mL within 1 month prior to the start of this trial, or 400 mL within 3 months prior. Individuals who have previously experienced discomfort or worsening health following blood collection. Individuals with food allergy symptoms, or those at risk of developing them. Smokers. Regular alcohol drinkers. Individuals who routinely engage in strenuous exercise. Individuals whose lifestyle habits may change during the study period (e.g., extended travel). Individuals who are currently taking, or have taken within the past 3 months, health functional foods on a continuous basis, or who plan to take them during the study period. Individuals who do not agree with the purpose of the study as explained during the pre-study briefing. Pregnant, breastfeeding, or potentially pregnant individuals. Individuals currently participating in another human clinical trial or those who have completed participation within the last 3 months. Other individuals deemed unsuitable for this trial by the responsible physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effects on lipid metabolism will be examined by analyzing the blood lipoprotein subclass profile before and after two weeks of consuming the test food (mushrooms). | — |
Countries
Japan
Contacts
Kagawa Nutrition University Laboratory of Food Chemistry